FDA Requires "Black Box" Warning on Antidepressants NAMI applauds the FDA for calling for close monitoring of youth living with depression and for providing better information about medications for treating depression in youth. However, the FDA's actions may also have unintended negative consequences.
Treating Kids with Depression New FDA warnings about the use of anti-depressant medications for children leave parents, caregivers wondering about options.
Living with Obsessive-Compulsive Disorder Welcome to NAMI's Living with Obsessive-Compulsive Disorder community. Here you will find support, get targeted information and connect with people who understand.
Prescription Drug Patient Assistance Programs Some pharmaceutical companies offer medication assistance programs to low-income individuals and families. This chart includes most psychotropic medications covered by such programs, as well as contact information for the pharmaceutical companies.